Cogstate Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cogstate Ltd with three other companies in this sector in AUSTRALIA : Clinuvel Pharmaceuticals Limited (2021 sales of 48.32 million Australian Dollars [US$35.22 million] of which 100% was Biotechnology), Pharmaxis Ltd (22.85 million Australian Dollars [US$16.65 million] of which 99% was Mannitol), and Idt Australia Limited. (16.93 million Australian Dollars [US$12.34 million] ).

Sales Analysis. During the year ended June of 2021, sales at Cogstate Ltd were A$43.77 million (US$31.90 million). This is an increase of 23.8% versus 2020, when the company's sales were A$35.36 million. Sales of Healthcare Market saw an increase of 43.4% in 2021, from A$3.51 million to A$5.03 million. Not all segments of Cogstate Ltd experienced an increase in sales in 2021: sales of Research fell 10.2% to A$347,890.41 . (However, this segment's sales were only a very small portion of the company's overall sales).